Immune monitoring by Torque Teno virus load in addition to virus-specific T cells after pediatric kidney transplantation
Clinical Kidney Journal · 01.09.2026 · 19 (9)
DOI: 10.1093/ckj/sfag262 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 17.08.2026. Verfasst von David Nehl und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics II, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University Hospital of Essen.
Abstract (Originalsprache)
Pharmacokinetic monitoring is insufficient to estimate the intensity of immunosuppression after kidney transplantation (Tx). The randomized controlled IVIST trial demonstrated that additional steering of immunosuppressive therapy by virus-specific CD4+ T cells (Tvis) is safe and reduces exposure to immunosuppressants. The adenovirus-specific CD4+ T cells (ADV-Tvis) proved to be particularly suitable due to their stability and high prevalence. Another promising biomarker for post-Tx immunomonitoring is the Torque Teno virus (TTV) but pediatric data are very limited. This descriptive longitudinal analysis aimed to evaluate the post-Tx course of TTV load compared to Tvis levels after pediatric Tx. In the IVIST trial, 31 pediatric kidney recipients were randomized to the intervention group with Tvis-guided immunosuppression. The immunosuppressive therapy consisted of basiliximab, cyclosporine A (CsA), everolimus (Eve), and prednisolone. In 27 out of 31 intervention group patients, TTV-DNA was analysed retrospectively in frozen plasma samples from 20 visits [1–24 months (mo) after Tx]. Associations of TTV-DNA with ADV-Tvis and with immunosuppressants over the post-Tx period were evaluated using linear mixed models, adjusted for time since Tx and accounting for repeated measurements within patients. Mean TTV-DNA (n = 474) ± standard deviation was 4.4 ± 1.3 log10 copies/ml (1.4 to 9.4 log10). TTV-DNA was associated with post-Tx follow-up time. Under intensive immunosuppression immediately after Tx, TTV-DNA increased, peaking at 3 mo post-Tx (5.5 ± 1.4 log10); after reduction of immunosuppression, TTV load decreased (6 mo: 4.3 ± 1.1 log10; 16 mo: 3.9 ± 0.9 log10). Mean ADV-Tvis levels showed a minimum at 2 mo post-Tx and increased over time: from 1.5 ± 1.1 cells/µl (2 mo) to 2.0 ± 1.8 cells/µl (6 mo) and 2.4 ± 1.7 cells/µl (22 mo). TTV-DNA showed overall positive correlations with mean daily doses and trough levels of CsA and Eve. The longitudinal analysis of TTV load presented an opposite post-Tx course compared to ADV-Tvis. TTV-DNA was associated with post-Tx follow-up time and with immunosuppressants after pediatric Tx. In comparison to ADV-Tvis minimum, the mean TTV-DNA showed a late peak at 3 mo post-Tx suggesting delayed response to drug dose changes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics II, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
- Institute for Biostatistics, Hannover Medical School, Hannover, Germany.
- Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
- Department of Pediatric Nephrology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
- Department of Pediatric Nephrology, Children's and Adolescents' Hospital, University Hospital of Cologne, Faculty of Medicine, Cologne, Germany.
- Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.
ORCID-Profile: Xiaofei Liu, Sebastian Voigt, Jun Oh, Lutz T Weber, Nele K Kanzelmeyer, Gregor Bond, Stefanie Jeruschke, Nils Pape, Anika Großhennig, Lars Pape, Thurid Ahlenstiel-Grunow
Förderung
- University Hospital of Essen
Zitieren
APA
Nehl, D., Liu, X., Voigt, S., Elsner, C., Schild, R., Oh, J., Taylan, C., Weber, L. T., Kanzelmeyer, N. K., Bond, G., Jeruschke, S., Pape, N., Großhennig, A., Pape, L., & Ahlenstiel-Grunow, T. (2026). Immune monitoring by Torque Teno virus load in addition to virus-specific T cells after pediatric kidney transplantation. Clinical Kidney Journal, 19(9). https://doi.org/10.1093/ckj/sfag262
Vancouver
Nehl D, Liu X, Voigt S, Elsner C, Schild R, Oh J, et al. Immune monitoring by Torque Teno virus load in addition to virus-specific T cells after pediatric kidney transplantation. Clinical Kidney Journal. 2026;19(9). doi:10.1093/ckj/sfag262
BibTeX
@article{Nehl2026,
author = {Nehl, David and Liu, Xiaofei and Voigt, Sebastian and Elsner, Carina and Schild, Raphael and Oh, Jun and Taylan, Christina and Weber, Lutz T and Kanzelmeyer, Nele K and Bond, Gregor and Jeruschke, Stefanie and Pape, Nils and Großhennig, Anika and Pape, Lars and Ahlenstiel-Grunow, Thurid},
title = {Immune monitoring by Torque Teno virus load in addition to virus-specific T cells after pediatric kidney transplantation},
journal = {Clinical Kidney Journal},
year = {2026},
volume = {19},
number = {9},
doi = {10.1093/ckj/sfag262}
}
EUVIMED